EssilorLuxottica Acquires Signifeye, a Belgian Ophthalmology Platform
EssilorLuxottica has announced the acquisition of Signifeye, a Belgian ophthalmology platform, as part of its expansion in Europe.
Continued Expansion in Europe
EssilorLuxottica, a leading player in the optics industry, continues its expansion in Europe with the acquisition of Signifeye, an established ophthalmology platform in Belgium. This transaction follows the recent purchase of Optegra, which operates over 70 clinics across several European countries. The integration of Signifeye is expected to strengthen EssilorLuxottica's presence in the ophthalmic care sector.
Enhancing Medical Services
According to the press release, Signifeye offers medical services in 15 clinics throughout Flanders, covering a wide range of eye health services. The acquisition is part of EssilorLuxottica's strategy to develop an integrated and innovative medical model, capable of meeting the diverse needs of patients in terms of eye care. The integration of Signifeye into the EssilorLuxottica ecosystem is also expected to enhance patient experience.
Strengthening Market Position
EssilorLuxottica views this acquisition as a way to strengthen Optegra's position in Europe and to advance in its med-tech trajectory. The completion of this transaction is expected by the first quarter of 2026. EssilorLuxottica's leaders, Francesco Milleri and Paul du Saillant, along with Signifeye's General Manager, Kathleen Moons, have expressed optimism about this new phase of joint development.
